Cargando…
Developing a core outcome set for assessing clinical safety outcomes of cardiovascular diseases in clinical trials of integrated traditional Chinese medicine and Western medicine: study protocol
BACKGROUND: Integrative medicine is commonly used in China. Researchers prefer to report efficacy outcomes rather than safety outcomes in clinical trials; thus, evidence regarding safety in integrative medicine is unclear. Developing a core outcome set (COS) for safety outcomes is necessary. In this...
Autores principales: | Qiu, Ruijin, Zhong, Changming, Wan, Siqi, Zhang, Yao, Wei, Xuxu, Li, Min, Hu, Jiayuan, Chen, Shiqi, Zhao, Chen, Chen, Zhao, Chen, Jing, Shang, Hongcai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962576/ https://www.ncbi.nlm.nih.gov/pubmed/35346338 http://dx.doi.org/10.1186/s13063-022-06166-3 |
Ejemplares similares
-
Development of a Core Outcome Set for the Benefits and Adverse Events of Acute Heart Failure in Clinical Trials of Traditional Chinese Medicine and Western Medicine: A Study Protocol
por: Qiu, Ruijin, et al.
Publicado: (2021) -
Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine
por: Qiu, Ruijin, et al.
Publicado: (2020) -
Development of a core outcome set for myocardial infarction in clinical trials of traditional Chinese medicine: a study protocol
por: Qiu, Ruijin, et al.
Publicado: (2019) -
Development of a core outcome set (COS) and selecting outcome measurement instruments (OMIs) for non-valvular atrial fibrillation in traditional Chinese medicine clinical trials: study protocol
por: Qiu, Ruijin, et al.
Publicado: (2018) -
Outcome reporting from clinical trials of non-valvular atrial fibrillation treated with traditional Chinese medicine or Western medicine: a systematic review
por: Qiu, Ruijin, et al.
Publicado: (2019)